GSTC — GlobeStar Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- $0.37m
Annual cashflow statement for GlobeStar Therapeutics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.675 | -0.542 | -9.8 | -1.49 | -1.95 |
| Depreciation | |||||
| Non-Cash Items | 0.402 | 0.298 | 8.83 | 0.716 | 1.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.013 | 0.002 | 0.221 | 0.445 | 0.447 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.26 | -0.24 | -0.751 | -0.327 | -0.206 |
| Capital Expenditures | 0 | -0.002 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.002 | 0 | — | — |
| Financing Cash Flow Items | — | — | — | 0.012 | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.269 | 0.223 | 0.676 | 0.327 | 0.199 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.009 | -0.019 | -0.075 | 0 | -0.006 |